Dr. Josep Dalmau, new member of the National Academy of Medicine of the United States
Dr. Josep Dalmau, ICREA researcher at IDIBAPS, where leads the Autoimmune Pathogenesis of Neuronal Diseases group, Professor of Neurology at the Un1
Dr. Josep Dalmau, ICREA researcher at IDIBAPS, where leads the Autoimmune Pathogenesis of Neuronal Diseases group, Professor of Neurology at the Un1
Eva Calvo, Juan Miguel Cejalvo and Alberto Indacochea are the three physicians who, this October, will be admitted to the PhD for Medical Doctors Pr1
A study published by the New England Journal of Medicine and led by ISGlobal and the Manhiça Health Research Center (CISM) in Mozambique, shows that1
On October 1st, about forty patients with type 1 diabetes participated in the First Forum of Diabetes and Sports, organized by the Unit of Diabetes1
Researchers from Hospital Clínic and IDIBAPS have published a review on bipolar disorder in the prestigious journal The Lancet. It is an update on t1
Dr. Jordi Bruix, group leader of the Networked Biomedical Research Center for Hepatic and Digestive Diseases (CIBEREHD) at Hospital Clínic and IDIBAP1
A study led by researchers from Hospital Clínic and IDIBAPS defines more precisely the risk of developing colon cancer in patients with serrated pol1
The Translational Reserarch in Hepatic Oncology IDIBAPS group, led by Dr. Josep M. Llovet, in collaboration with Dr. Roser Pinyol and 8 more researc1
Researchers from the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and the Hospital Clínic of Barcelona, in collaboration with qGenomics1
A study published in the New England Journal of Medicine (NEJM) shows that the combination of two drugs (ambrisentan and tadalafil) is more effective1